N/A
Completed N=60
Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function
Source: ClinicalTrials.gov NCT00881335 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Jun 2012
Primary outcomePrimary: Number of Cases With Fever (Body Temperature Reach 38 Degree Celsius or Higher) — 0; 2 participants
Summary
The purpose of this study is to evaluate the clinical outcome and safety of flutter mucus clearance devices in elders of gerocomium.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Cases With Fever (Body Temperature Reach 38 Degree Celsius or Higher) |
0; 2 | — |
| PRIMARY MPEF,Mean Peak Expiratory Flow |
117.59; 103.93 | — |
| PRIMARY FEV1, Forced Expiratory Volume at First Second |
1.01; 1.02 | — |
| PRIMARY FVC, Forced Vital Capacity |
2.06; 1.77 | — |
| PRIMARY FEV1/FVC%, the Ratio of FEV1 to FVC |
50.67; 59.04 | — |
| SECONDARY Number of Cases With Antibiotics Therapy |
1; 3 | — |
| SECONDARY Number of Cases With Hospital Visit |
2; 3 | — |
Eligibility Criteria
Inclusion Criteria
- available to perform the device, the elders in geracomium
- male and female
- aging 85 years or more
Exclusion Criteria
- not available to perform the procedure
- untreated pneumothorax
- diffusion interstitial lung disease
- acute coronary syndrome
- third stage hypertension
- advanced cancer
- severe heart, liver, renal, blood system and endocrine system dysfunction
- noninvasive mechanical ventilation
- active hemoptysis
Data sourced from ClinicalTrials.gov (NCT00881335). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.